News
Media
Medical World NewsPodcastsVideosInsightsPeer ExchangeMedia DayNews NetworkRoundtables
Conference
Conference CoverageConference Listing
Publication
More
CME/CE
Partners
Resources
Interactive ToolsSpecial ProjectsSponsored
Contribute
Case StudiesWriters and Mentors

Subscribe

  • News
  • Media
  • Conference
  • Publication
  • CME/CE
  • Partners
  • Resources
  • Contribute
  • Subscribe
  • Antimicrobial Stewardship
  • Blood-Borne Diseases
    • Ebola
    • HCV / Hepatitis
  • Coronavirus / COVID
  • Food Borne Infection / Food Safety
    • E. Coli
    • Food Safety
    • Listeria
    • Salmonella
  • Fungal Infections
    • Candida auris
  • Gastrointestinal Infections
    • C. Difficile
    • H. Pylori
    • Norovirus
  • Healthcare Associated Infections (HAI)
  • Prevention
    • Antibiotics
    • Immunizations
    • Vaccines
  • Respiratory Infections
    • Community-Acquired Pneumonia
    • Measles
    • Influenza
  • Sexually Transmitted Diseases
    • HIV / AIDS
    • HPV
    • HSV
    • PrEP
  • Skin & Soft Tissue Diseases
    • MRSA
  • Zoonotic & Vector-Borne Diseases
    • Lyme Disease
    • ZIKA
Spotlight -
Antimicrobial Stewardship|
Bench to Bedside With SIDP|
C. difficile |
Clinical Corner|
Fungal Infections|
Hepatitis|
RSV: A New Era in Prevention
Advertisement

Christina G. Rivera, PharmD, BCPS

Advertisement

Articles by Christina G. Rivera, PharmD, BCPS

ID Consultation Associated With Reductions in ED Visits, Hospital Admissions, and Cost for OPAT Patients

ByChristina G. Rivera, PharmD, BCPS
April 18th 2019

This In the Literature piece details a study evaluating the effects of ID consultation for OPAT patients.

Advertisement

Latest Updated Articles

  • ID Consultation Associated With Reductions in ED Visits, Hospital Admissions, and Cost for OPAT Patients
    ID Consultation Associated With Reductions in ED Visits, Hospital Admissions, and Cost for OPAT Patients

    Published: April 18th 2019 | Updated:



Advertisement
Advertisement

Trending on Contagion Live

1

Developing a COVID-19 Vaccine Alternative

2

Real-World Data Reinforce Effectiveness and Safety of Fecal Microbiota Therapy for Preventing Recurrent C difficile

3

Generic Lenacapavir Could Cost as Little as $25 Per Person Annually

4

Early, Aggressive Treatment and Shorter Antibiotic Courses Shape Modern Pneumonia Discharge Practices

5

Practically Expanding AI's role in Infectious Diseases

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Do Not Sell My Information
  • Privacy
  • Terms & Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us